List view / Grid view
University of Leicester
10 August 2018 | By European Pharmaceutical Review
“We will work with health care professionals and patients to develop a form of rehabilitation that will be acceptable to all those involved."
8 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Health Data Research UK is awarding £30 million funding to six sites across the UK to address challenging healthcare issues through the use of data science...
11 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Pharmaceutical companies are sponsoring a project to generate, align and share disease-level data across an entire condition for health technology assessments...
17 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have identified that the drug semaglutide resulted in better glycemic control than placebo for patients with type 2 diabetes...
27 July 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
US science minister announce new multi-million-pound commitment to boost the burgeoning field of cryo-electron microscopy (cryo-EM) in the UK.
27 March 2017 | By Niamh Marriott (European Pharmaceutical Review)
New research projects that aim to improve the complex formulation processes used to manufacture products such as toothpastes, inhalers, films that coat solar cells and pharmaceuticals are to receive significant funding from the Engineering and Physical Sciences Research Council (EPSRC).
21 July 2016 | By Niamh Louise Marriott, Digital Content Producer
global pharmaceutical company GlaxoSmithKline has been established to discover and develop novel medicines to treat aggressive forms of blood cancer...
10 May 2016 | By Victoria White, Digital Content Producer
Researchers have shown a modified dosage rtPA can reduce serious bleeding in the brain and improve survival rates in patients with acute stroke...
11 November 2015 | By Victoria White
The clinical trial, a first-in-man study, looked at the efficacy of ONO/GS-4059 in the treatment of Chronic Lymphocytic Leukaemia and Non-Hodgkin Lymphoma patients...